BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23936368)

  • 1. Identification and characterization of multiple TRIM proteins that inhibit hepatitis B virus transcription.
    Zhang S; Guo JT; Wu JZ; Yang G
    PLoS One; 2013; 8(8):e70001. PubMed ID: 23936368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripartite Motif-Containing Protein 65 (TRIM65) Inhibits Hepatitis B Virus Transcription.
    Shen S; Yan R; Xie Z; Yu X; Liang H; You Q; Zhang H; Hou J; Zhang X; Liu Y; Sun J; Guo H
    Viruses; 2024 May; 16(6):. PubMed ID: 38932182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 protein.
    Zhao F; Xu G; Zhou Y; Wang L; Xie J; Ren S; Liu S; Zhu Y
    J Biol Chem; 2014 Dec; 289(50):35029-41. PubMed ID: 25342750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopetrosis-Associated Transmembrane Protein 1 Recruits RNA Exosome To Restrict Hepatitis B Virus Replication.
    Ma C; Xu W; Yang Q; Liu W; Xiang Q; Chen J; Zhang Q; Liu Y; Wu K; Wu J
    J Virol; 2020 May; 94(11):. PubMed ID: 32188736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tripartite motif-containing protein 21 is involved in IFN-γ-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors.
    Won J; Kang HS; Kim NY; Dezhbord M; Marakkalage KG; Lee E-H; Lee D; Park S; Kim D-S; Kim K-H
    J Virol; 2024 Jun; 98(6):e0046824. PubMed ID: 38780244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
    Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
    J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter.
    Ibrahim MK; Abdelhafez TH; Takeuchi JS; Wakae K; Sugiyama M; Tsuge M; Ito M; Watashi K; El Kassas M; Kato T; Murayama A; Suzuki T; Chayama K; Shimotohno K; Muramatsu M; Aly HH; Wakita T
    J Virol; 2021 Jul; 95(15):e0076721. PubMed ID: 33980595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Vesicular Stomatitis Virus Infection.
    Patil G; Xu L; Wu Y; Song K; Hao W; Hua F; Wang L; Li S
    Viruses; 2020 Jan; 12(2):. PubMed ID: 31979016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication.
    Pei R; Qin B; Zhang X; Zhu W; Kemper T; Ma Z; Trippler M; Schlaak J; Chen X; Lu M
    J Innate Immun; 2014; 6(2):182-91. PubMed ID: 23867918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    Nair S; Zlotnick A
    J Virol; 2018 May; 92(10):. PubMed ID: 29491156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX9 represses hepatitis B virus replication through binding to HBV EnhII/Cp and inhibiting the promoter activity.
    Yang H; Zhou Y; Mo J; Xiang Q; Qin M; Liu W; Shang J; Yang Q; Xu W; Yang G; Tan Q; Wu K; Liu Y; Wu J
    Antiviral Res; 2020 May; 177():104761. PubMed ID: 32147495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection.
    Patil G; Zhao M; Song K; Hao W; Bouchereau D; Wang L; Li S
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
    Gao B; Duan Z; Xu W; Xiong S
    Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity.
    Tian X; Dong H; Lai X; Ou G; Cao J; Shi J; Xiang C; Wang L; Zhang X; Zhang K; Song J; Deng J; Deng H; Lu S; Zhuang H; Li T; Xiang K
    Antiviral Res; 2022 Nov; 207():105406. PubMed ID: 36084850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX2 Represses Hepatitis B Virus Replication by Binding to the Viral EnhII/Cp and Inhibiting the Promoter Activation.
    Yang H; Mo J; Xiang Q; Zhao P; Song Y; Yang G; Wu K; Liu Y; Liu W; Wu J
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.
    Mao R; Nie H; Cai D; Zhang J; Liu H; Yan R; Cuconati A; Block TM; Guo JT; Guo H
    PLoS Pathog; 2013; 9(7):e1003494. PubMed ID: 23853601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
    Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
    J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
    Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of interferon-stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter.
    Park YK; Lee SY; Lee AR; Kim KC; Kim K; Kim KH; Choi BS
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1426-1436. PubMed ID: 31951295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.